Purchase Order 15B10926P00000015

McKesson Corporation, a major pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, was awarded a firm fixed-price purchase order by the Federal Medical Center Lexington on December 1, 2025, for $19,749.70. The contract covers the provision of Medication-Assisted Treatment (MAT) medications—both controlled and non-controlled—for the period from January 1 through December 31, 2026, under McKesson's existing account numbers 077960 and 677508. The award was made without a set-aside designation, reflecting McKesson's status as a large business contractor competing in the open federal marketplace. The place of performance is listed as Irving, Texas, where McKesson maintains its corporate headquarters and primary distribution operations.

The Federal Medical Center Lexington, a civilian facility operating under the Bureau of Prisons within the Department of Justice, utilizes this purchase order to support its healthcare operations and inmate medical services. McKesson's extensive federal contracting history demonstrates its critical role as a pharmaceutical supplier to correctional facilities, veterans' healthcare networks, and other federal agencies, with particular expertise in delivering controlled substances and specialty medications required for federal healthcare settings. This purchase order represents a continuation of McKesson's established relationship with federal correctional healthcare providers, enabling the facility to maintain consistent access to essential MAT medications necessary for inmate healthcare and substance abuse treatment programming.